Jump to Main Content
PubAg
Main content area
Search
« Previous |
1 - 20 of 603
|
Next »
Search Results
- Author:
- Chang, Chia-Yuan; Cho, Ching-Yi; Lai, Chou-Cheng; Lu, Chun-Yi; Chang, Luan-Yin; Hung, Miao-Chiu; Huang, Li-Min; Wu, Keh-Gong
- Source:
- Vaccine 2020 v.38 no.22 pp. 3839-3846
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; children; hemagglutination; humans; immunogenicity; influenza; seroconversion; vaccination; Taiwan; Show all 9 Subjects
- Abstract:
- ... Quadrivalent influenza vaccines are particularly valuable during seasons in which a mismatch occurs between the predicted influenza B lineage for the trivalent influenza vaccine and the circulating strain. This study evaluated the immunogenicity and safety of a quadrivalent inactivated influenza vaccine AdimFlu-S manufactured in Taiwan for the 2016–2017 influenza season in healthy children.A total ...
- DOI:
- 10.1016/j.vaccine.2020.03.048
-
https://dx.doi.org/10.1016/j.vaccine.2020.03.048
- Author:
- Baker, Meghan A.; Jankosky, Christopher; Yih, W. Katherine; Gruber, Susan; Li, Lingling; Cocoros, Noelle M.; Lipowicz, Hana; Coronel-Moreno, Claudia; DeLuccia, Sandra; Lin, Nancy D.; McMahill-Walraven, Cheryl N.; Menschik, David; Selvan, Mano S.; Selvam, Nandini; Chen Tilney, Rong; Zichittella, Lauren; Lee, Grace M.; Kawai, Alison Tse
- Source:
- Vaccine 2020 v.38 no.9 pp. 2166-2171
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; Streptococcus pneumoniae; children; influenza; risk; seizures; Show all 6 Subjects
- Abstract:
- ... Evidence on the risk of febrile seizures after inactivated influenza vaccine (IIV) and 13-valent pneumococcal conjugate vaccine (PCV13) is mixed. In the FDA-sponsored Sentinel Initiative, we examined risk of febrile seizures after IIV and PCV13 in children 6–23 months of age during the 2013–14 and 2014–15 influenza seasons.Using claims data and a self-controlled risk interval design, we compared t ...
- DOI:
- 10.1016/j.vaccine.2020.01.046
-
https://dx.doi.org/10.1016/j.vaccine.2020.01.046
- Author:
- Porter, Rachael M.; Goldin, Shoshanna; Lafond, Kathryn E.; Hedman, Lisa; Ungkuldee, Mellissa; Kurzum, Jordan; Azziz-Baumgartner, Eduardo; Nannei, Claudia; Bresee, Joseph S.; Moen, Ann
- Source:
- Vaccine 2020 v.38 no.5 pp. 1152-1159
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; confidence interval; influenza; models; monitoring; pandemic; vaccination; Show all 7 Subjects
- Abstract:
- ... National seasonal influenza programs have been recommended as a foundation for pandemic preparedness. During the 2009 pandemic, WHO aimed to increase Member States’ equitable access to influenza vaccines through pandemic vaccine donation.This analysis explores whether the presence of a seasonal influenza program contributed to more rapid national submission of requirements to receive vaccine durin ...
- DOI:
- 10.1016/j.vaccine.2019.11.025
- PubMed:
- 31839465
- PubMed Central:
- PMC6992512
-
https://dx.doi.org/10.1016/j.vaccine.2019.11.025
- Author:
- Ma, Wenjun
- Source:
- Virus research 2020 v.288 pp. 198118
- ISSN:
- 0168-1702
- Subject:
- influenza vaccines, etc ; Influenza A virus; disease control; genotype; humans; pandemic; pork industry; swine; swine influenza; Show all 9 Subjects
- Abstract:
- ... Since swine influenza virus was first isolated in 1930, it has become endemic in pigs worldwide. Although large amount of swine influenza vaccines has been used in swine industry, swine influenza still cannot be efficiently controlled and has been an important economic disease for swine industry. The high diversity and varied distribution of different subtypes and genotypes of swine influenza viru ...
- DOI:
- 10.1016/j.virusres.2020.198118
-
https://dx.doi.org/10.1016/j.virusres.2020.198118
- Author:
- Berce, Philip C.; Bernstein, Rebecca S.; MacKinnon, George E.; Sorum, Sarah; Martin, Erica; MacKinnon, Karen J.; Rein, Lisa E.; Schellhase, Kenneth G.
- Source:
- Vaccine 2020 v.38 no.28 pp. 4448-4456
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; Papillomaviridae; attitudes and opinions; health insurance; issues and policy; patients; physicians; surveys; vaccination; Wisconsin; Show all 10 Subjects
- Abstract:
- ... There is currently limited data in the United States on the proportion of immunization doses given at pharmacies outside the influenza vaccine. This study aims to obtain baseline information on the percentage of vaccine doses administered at pharmacies in Wisconsin and to understand the immunization barriers for Wisconsin pharmacists, to inform interventions to increase immunization access at phar ...
- DOI:
- 10.1016/j.vaccine.2020.04.043
-
https://dx.doi.org/10.1016/j.vaccine.2020.04.043
- Author:
- Wraith, Steph; Nachbagauer, Raffael; Balmaseda, Angel; Stadlbauer, Daniel; Ojeda, Sergio; Rajabhathor, Arvind; Lopez, Roger; Guglia, Andrea F.; Sanchez, Nery; Amanat, Fatima; Gresh, Lionel; Kuan, Guillermina; Krammer, Florian; Gordon, Aubree
- Source:
- Vaccine 2020 v.38 no.27 pp. 4221-4225
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; antibodies; antibody formation; hemagglutinins; humoral immunity; influenza; polymerase chain reaction; sialidase; Show all 8 Subjects
- Abstract:
- ... We investigated humoral immune response to influenza A(H1N1)pdm infection and found 32 (22%) of the infected individuals identified by PCR failed to produce a ≥ 4-fold hemagglutinin inhibition assay (HAI) response; a subset of 18 (56%) produced an alternate antibody response (against full-length HA, HA stalk, or neuraminidase). These individuals had lower pre-existing HAI antibody titers and showe ...
- DOI:
- 10.1016/j.vaccine.2020.04.069
-
https://dx.doi.org/10.1016/j.vaccine.2020.04.069
- Author:
- Ahmed, May A.; Naus, Monika; Singer, Joel; Valiquette, Louis; Coleman, Brenda L.; De Serres, Gaston; Vanderkooi, Otto G.; Top, Karina A.; Isenor, Jennifer E.; Kellner, James D.; McCarthy, Anne E.; Bettinger, Julie A.
- Source:
- Vaccine 2020 v.38 no.19 pp. 3582-3590
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; anesthesia; clinical trials; headache; influenza vaccination; odds ratio; regression analysis; Canada; Show all 8 Subjects
- Abstract:
- ... Concern about adverse events following immunization is frequently cited by both those who receive or decline vaccines. Neurological adverse events are especially concerning.Our aim was to detect associations between seasonal influenza vaccination and the occurrence of severe anesthesia/paresthesia or severe headaches.Data were analyzed from the Canadian National Vaccine Safety network. Events occu ...
- DOI:
- 10.1016/j.vaccine.2020.03.018
-
https://dx.doi.org/10.1016/j.vaccine.2020.03.018
- Author:
- O'Leary, Sean T.; Cataldi, Jessica R.; Lindley, Megan C.; Hurley, Laura P.; Riley, Laura E.; Brtnikova, Michaela; Crane, Lori A.; Beaty, Brenda; Stokley, Shannon; Fisher, Allison; Kempe, Allison
- Source:
- Vaccine 2020 v.38 no.18 pp. 3474-3479
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; abortion (animals); attitudes and opinions; influenza; influenza vaccination; patients; pregnant women; risk; surveys; Show all 9 Subjects
- Abstract:
- ... In 2017, three media stories regarding influenza vaccine may have impacted obstetricians’ (OB) influenza vaccination practices: reports of reduced influenza vaccine effectiveness, a severe influenza season, and a possible increased risk of miscarriage among pregnant women receiving 2009 H1N1 vaccine in the 1st trimester who had received H1N1 vaccine the previous season (later disproven).Describe O ...
- DOI:
- 10.1016/j.vaccine.2020.02.051
-
https://dx.doi.org/10.1016/j.vaccine.2020.02.051
- Author:
- Hoeve, Christina E.; Gadroen, Kartini; Kwa, Marcel S.G.; van Haren, Anja; Sturkenboom, Miriam C.J.M.; Straus, Sabine M.J.M.
- Source:
- Vaccine 2020 v.38 no.15 pp. 3086-3095
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; Streptococcus pneumoniae; adverse effects; education; immunization; live vaccines; measles; patients; quality control; rabies; screening; Show all 11 Subjects
- Abstract:
- ... Serious adverse reactions after immunization are rare but do occur. In very rare instances, cases with fatal outcome have been reported. These reports can have a huge impact and even more so when due to an immunization error. The aim of this study is to systematically review immunization errors with fatal outcomes in EudraVigilance.This was a case-series analysis of Individual Case Safety Reports ...
- DOI:
- 10.1016/j.vaccine.2020.02.074
-
https://dx.doi.org/10.1016/j.vaccine.2020.02.074
- Author:
- Kalligeros, Markos; Shehadeh, Fadi; Mylona, Evangelia K.; Dapaah-Afriyie, Christine; van Aalst, Robertus; Chit, Ayman; Mylonakis, Eleftherios
- Source:
- Vaccine 2020 v.38 no.14 pp. 2893-2903
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; children; databases; elderly; influenza; influenza vaccination; meta-analysis; risk; systematic review; Show all 9 Subjects
- Abstract:
- ... Vaccination remains the most effective way to prevent influenza infection, albeit vaccine effectiveness (VE) varies by year. Compared to other age groups, children and elderly adults have the highest risk of developing influenza-related complications and requiring hospitalization. During the last years, “test negative design” (TND) studies have been implemented in order to estimate influenza VE. T ...
- DOI:
- 10.1016/j.vaccine.2020.02.049
-
https://dx.doi.org/10.1016/j.vaccine.2020.02.049
- Author:
- Akpalu, Yao; Sullivan, Seth J.; Regan, Annette K.
- Source:
- Vaccine 2020 v.38 no.9 pp. 2132-2135
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; adults; health insurance; health services; influenza; influenza vaccination; medical records; regression analysis; risk; Texas; Show all 10 Subjects
- Abstract:
- ... Lack of health insurance may limit access to influenza vaccination, resulting in higher risk of infection.The Brazos County Health Department obtained medical records summarizing vaccination and health insurance status of all influenza cases occurring in December 2017 (n = 417). The odds of influenza vaccination were estimated for those with public or private health insurance as compared to uninsu ...
- DOI:
- 10.1016/j.vaccine.2020.01.029
-
https://dx.doi.org/10.1016/j.vaccine.2020.01.029
- Author:
- Sandhu, Sukhminder K.; Hua, Wei; MaCurdy, Thomas E.; Franks, Riley L.; Avagyan, Armen; Chillarige, Yoganand; Wernecke, Michael; Kelman, Jeffrey; Ball, Robert
- Source:
- Vaccine 2020 v.38 no.9 pp. 2221-2228
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; Guillain-Barre Syndrome; influenza; influenza vaccination; monitoring; relative risk; United States; Show all 7 Subjects
- Abstract:
- ... Near real-time surveillance of the influenza vaccine, which is administered to a large proportion of the US population every year, is essential to ensure safety of the vaccine. For efficient near real-time surveillance, it is key to select appropriate parameters such as monitoring start date, number of interim tests and a scheme for spending a pre-defined total alpha across the entire influenza se ...
- DOI:
- 10.1016/j.vaccine.2019.12.032
-
https://dx.doi.org/10.1016/j.vaccine.2019.12.032
- Author:
- Castilla, Jesús; Portillo, María Eugenia; Casado, Itziar; Pozo, Francisco; Navascués, Ana; Adelantado, Marta; Gómez Ibáñez, Carlos; Ezpeleta, Carmen; Martínez-Baz, Iván
- Source:
- Vaccine 2020 v.38 no.8 pp. 1925-1932
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; confidence interval; general practitioners; hospitals; influenza; influenza vaccination; patients; protective effect; California; Michigan; Spain; Show all 11 Subjects
- Abstract:
- ... The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018–2019 season.Influenza-like illness patients attended by sentinel general practitioners or ...
- DOI:
- 10.1016/j.vaccine.2020.01.028
-
https://dx.doi.org/10.1016/j.vaccine.2020.01.028
- Author:
- Lutz, Chelsea S.; Fink, Rebecca V.; Cloud, Ann J.; Stevenson, John; Kim, David; Fiebelkorn, Amy Parker
- Source:
- Vaccine 2020 v.38 no.6 pp. 1393-1401
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; Internet; adults; influenza; morbidity; mortality; surveys; t-test; vaccination; United States; Show all 10 Subjects
- Abstract:
- ... Annual vaccination against seasonal influenza is widely recognized as the primary intervention method in preventing morbidity and mortality from influenza, but coverage among adults is suboptimal in the United States. Safety and effectiveness perceptions regarding vaccines are consistently cited as factors that influence adults’ decisions to accept or reject vaccination. Therefore, we conducted th ...
- DOI:
- 10.1016/j.vaccine.2019.12.004
-
https://dx.doi.org/10.1016/j.vaccine.2019.12.004
- Author:
- Mallory, Raburn M.; Nyborg, Andrew; Kalyani, Rubana N.; Yuan, Yuan; Block, Stan L.; Dubovsky, Filip
- Source:
- Vaccine 2020 v.38 no.5 pp. 1001-1008
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; children; hemagglutination; immunogenicity; immunoglobulin A; influenza; live vaccines; males; neutralizing antibodies; nose; Bolivia; Slovenia; Show all 12 Subjects
- Abstract:
- ... Quadrivalent live attenuated influenza vaccine (LAIV4) showed reduced effectiveness against the A/H1N1 component in the 2013–2014 and 2015–2016 influenza seasons. The most likely cause of reduced LAIV effectiveness against A(H1N1)pdm09 strains was poor intranasal replication.To compare the immunogenicity and shedding of a new A/H1N1 strain (A/Slovenia), to a A/H1N1 strain known to have reduced eff ...
- DOI:
- 10.1016/j.vaccine.2019.11.055
-
https://dx.doi.org/10.1016/j.vaccine.2019.11.055
- Author:
- Nowak, Glen J.; Evans, Nathaniel J.; Wojdynski, Bartosz W.; Ahn, Sun Joo (Grace); Len-Rios, Maria E.; Carera, Karen; Hale, Scott; McFalls, Deborah
- Source:
- Vaccine 2020 v.38 no.5 pp. 1225-1233
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; adults; computer simulation; education; experimental design; herd immunity; influenza; influenza vaccination; pamphlets; United States; Show all 10 Subjects
- Abstract:
- ... Only one-third of adults 18–49 years old in the United States receive a recommended annual influenza vaccination. This study examined whether supplementing vaccine information statements (VIS) with an immersive virtual reality (VR), short video or electronic pamphlet story designed to convey the community immunity benefits of influenza vaccination would improve influenza vaccine avoidant participa ...
- DOI:
- 10.1016/j.vaccine.2019.11.009
-
https://dx.doi.org/10.1016/j.vaccine.2019.11.009
- Author:
- Gao, Zhizeng; Robinson, Kyle; Skowronski, Danuta M.; De Serres, Gaston; Withers, Stephen G.
- Source:
- Vaccine 2020 v.38 no.4 pp. 715-718
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; fluorometry; immune response; influenza; sialidase; surface proteins; titration; North America; Show all 8 Subjects
- Abstract:
- ... The protective immunological effects of the influenza neuraminidase (NA) surface protein are of renewed interest but NA content in vaccines remains unstandardized and methods to easily and reliably quantify NA content are unsatisfactory. We describe the use of a recently developed fluorometric titration reagent, TR1, to efficiently quantify the total enzymatically active NA content of six commerci ...
- DOI:
- 10.1016/j.vaccine.2019.11.041
-
https://dx.doi.org/10.1016/j.vaccine.2019.11.041
- Author:
- Otten, Gillis; Matassa, Vincent; Ciarlet, Max; Leav, Brett
- Source:
- Vaccine 2020 v.38 no.3 pp. 578-587
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; adjuvants; adults; antigens; clinical trials; confidence interval; hemagglutination; immunogenicity; seroconversion; vaccination; Show all 10 Subjects
- Abstract:
- ... To assess the safety and immunogenicity of the MF59®-adjuvanted trivalent influenza vaccine (aTIV; Fluad®) compared with modified aTIV formulations.A total of 196 subjects ≥ 65 years were randomized to receive7different formulations of vaccine containing a range of adjuvant and antigen dosesby single injection, or divided into two injections at a single time point. The primary study objective was ...
- DOI:
- 10.1016/j.vaccine.2019.10.058
-
https://dx.doi.org/10.1016/j.vaccine.2019.10.058
- Author:
- Pebody, Richard G.; Whitaker, Heather; Ellis, Joanna; Andrews, Nick; Marques, Diogo F.P.; Cottrell, Simon; Reynolds, Arlene J.; Gunson, Rory; Thompson, Catherine; Galiano, Monica; Lackenby, Angie; Robertson, Chris; O'Doherty, Mark G.; Owens, Katie; Yonova, Ivelina; Shepherd, Samantha J.; Moore, Catherine; Johnston, Jillian; Donati, Matthew; McMenamin, Jim; Lusignan, Simon de; Zambon, Maria
- Source:
- Vaccine 2020 v.38 no.3 pp. 489-497
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; adults; childhood; children; control methods; influenza; influenza vaccination; live vaccines; United Kingdom; Show all 9 Subjects
- Abstract:
- ... 2018/19 was the first season of introduction of a newly licensed adjuvanted influenza vaccine (aTIV) for adults aged 65 years and over and the sixth season in the roll-out of a childhood influenza vaccination programme with a quadrivalent live attenuated influenza vaccine (LAIV). The season saw mainly A(H1N1)pdm09 and latterly A(H3N2) circulation.End-of-season adjusted vaccine effectiveness (aVE) ...
- DOI:
- 10.1016/j.vaccine.2019.10.071
-
https://dx.doi.org/10.1016/j.vaccine.2019.10.071
- Author:
- Pebody, R.G.; Zhao, H.; Whitaker, H.J.; Ellis, J.; Donati, M.; Zambon, M.; Andrews, N.
- Source:
- Vaccine 2020 v.38 no.2 pp. 158-164
- ISSN:
- 0264-410X
- Subject:
- influenza vaccines, etc ; children; general practitioners; influenza; live vaccines; monitoring; reverse transcriptase polymerase chain reaction; England; Show all 8 Subjects
- Abstract:
- ... 2013/14 saw the start of the introduction of a new live attenuated influenza vaccine (LAIV) programme for children in England. 2018/19 saw co-circulation of both A(H1N1)pdm09 and A(H3N2), when LAIV was offered to all healthy children 2–9 years of age. LAIV effectiveness against influenza hospitalisation is not well described. This paper presents the 2018/19 end-of-season adjusted vaccine effective ...
- DOI:
- 10.1016/j.vaccine.2019.10.035
-
https://dx.doi.org/10.1016/j.vaccine.2019.10.035